Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Profiling Dectin-2-Positive Tumor-Associated Macrophages Across Human Cancers by Immunohistochemistry.
Journal: Laboratory investigation; a journal of technical methods and pathology
Published: November 25, 2025
Development of a Novel IHC Assay for PD-L1 Detection in Non-Small Cell Lung Cancer.
Journal: Biomedicines
Published: July 28, 2025
The Value of Companion Diagnostics.
Journal: The journal of applied laboratory medicine
Published: May 08, 2020
Prevalence Study of PD-L1 SP142 Assay in Metastatic Triple-negative Breast Cancer.
Journal: Applied immunohistochemistry & molecular morphology : AIMM
Published: December 20, 2019
Development of a PD-L1 Complementary Diagnostic Immunohistochemistry Assay (SP142) for Atezolizumab.
Development of a PD-L1 Complementary Diagnostic Immunohistochemistry Assay (SP142) for Atezolizumab.
Journal: Applied immunohistochemistry & molecular morphology : AIMM
Published: January 19, 2018
PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: November 14, 2016
Rovalpituzumab tesirine, a DLL3-targeted antibody-drug conjugate, in recurrent small-cell lung cancer: a first-in-human, first-in-class, open-label, phase 1 study.
Journal: The Lancet. Oncology
Published: July 28, 2016
Evaluating clinical and prognostic implications of Glypican-3 in hepatocellular carcinoma.
Journal: Oncotarget
Published: June 16, 2016
Quantitative and qualitative characterization of Two PD-L1 clones: SP263 and E1L3N.
Journal: Diagnostic pathology
Published: February 05, 2016
Showing 1-9 of 9
Last Updated: 09/26/2026